Calithera Biosciences, Inc.·4

Mar 6, 4:08 PM ET

Molineaux Christopher 4

4 · Calithera Biosciences, Inc. · Filed Mar 6, 2018

Insider Transaction Report

Form 4
Period: 2018-03-02
Molineaux Christopher
SR. VP, DEVELOPMENT
Transactions
  • Exercise/Conversion

    Common Stock

    2018-03-02$2.64/sh+6,798$17,94721,000 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-03-0226,9929,729 total(indirect: By Spouse)
    Exercise: $2.64Exp: 2023-12-16Common Stock (26,992 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-03-026,7980 total
    Exercise: $2.64Exp: 2023-12-16Common Stock (6,798 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    44,860
  • Common Stock

    (indirect: By Trust)
    349,190
Footnotes (3)
  • [F1]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 8, 2017.
  • [F2]Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee.
  • [F3]1/48 of the Option vests in equal monthly installments one month from 12/17/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION